SCHEMBL13953187

SCHEMBL13953187

C/C1=C2\C=CC(=N2)/C=C2/C=CC(=N2)/C=C2/C=CC(=N2)/C=C2/C=CC1=N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28444937 0.76 — —
SCHEMBL1946312 0.73 — —
SCHEMBL3522154 0.72 — —
SCHEMBL466965 0.71 — —
SCHEMBL8468863 0.70 — —
SCHEMBL6803316 0.66 — —
SCHEMBL15234444 0.66 — —
SCHEMBL28809817 0.65 HRH3 (0.35) —
SCHEMBL9744433 0.62 — —
SCHEMBL1962383 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042793-A1 Novel Antiviral Therapies K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2009-02-12 — — US disclosed
Send feedback